Integrated evaluation of uric acid, hs-CRP, and leukocyte count across preeclampsia severity among pregnant women in Al-Ahsa, Saudi Arabia: A cross-sectional study
Introduction: Preeclampsia (PE), a hypertensive disorder unique to pregnancy, is linked to systemic inflammation, endothelial dysfunction, and poor maternal and fetal outcomes.
Objectives: This study assessed serum uric acid, high-sensitivity C-reactive protein (hs-CRP), and total leukocyte count (TLC) in relation to preeclampsia severity, examining how well each marker discriminates individually and in combination—an analysis not previously undertaken in pregnant women from the Al-Ahsa region of Saudi Arabia.
Methods: This cross-sectional study included 58 pregnant women recruited in Al-Ahsa, Saudi Arabia: normotensive controls (n = 28), women with mild PE (n = 18), and women with severe PE (n = 12). Serum uric acid, hs-CRP, and TLC concentrations were determined for all participants and compared across groups using analysis of variance (ANOVA), the Kruskal–Wallis test, the Mann–Whitney U test, multivariate ANOVA, analysis of covariance, and receiver operating characteristic curve (ROC) analysis.
Results: Serum uric acid, hs-CRP, and TLC levels differed significantly across study groups (all p < 0.001), peaking in severe PE (uric acid: 343 ± 61 µmol/L; hs-CRP: 15 ± 3 mg/L; TLC: 11 ± 2 ×109/L). A significant overall effect of disease severity on the combined biomarker profile emerged on multivariate analysis, independent of maternal and gestational age, while ROC analysis indicated excellent-to-moderate accuracy for uric acid (area under the curve [AUC] = 0.92), hs-CRP (AUC = 0.88), and TLC (AUC = 0.75) in separating preeclampsia from normotensive pregnancy (all p < 0.001).
Conclusion: Serum uric acid, hs-CRP, and TLC are significantly associated with increasing PE severity and individually showed strong discriminatory performance, suggesting their potential value as adjunctive markers for inflammatory assessment in antenatal care, pending prospective validation.
- Robillard PY, Dekker G, Scioscia M, et al. Preeclampsia in 2023: time for preventing early-onset and term preeclampsia: the paramount role of gestational weight gain. J Reprod Immunol. 2023;158:103968. doi: 10.1016/j.jri.2023.103968
- Hegazy A, Eid FA, Ennab F, Sverrisdóttir YB, Atiomo W, Azar AJ. Prevalence of pre-eclampsia in women in the Middle East: a scoping review. Front Public Health. 2024;12:1384964. doi: 10.3389/fpubh.2024.1384964
- Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiology: review articles. Cardiovasc J Afr. 2016;27(2):71-78. doi: 10.5830/CVJA-2016-009
- Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-644. doi: 10.1016/S0140-6736(10)60279-6
- Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43. doi: 10.1161/HYPERTENSIONAHA.117.10803
- Subki AH, Algethami MR, Baabdullah WM, et al. Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: a retrospective study in Western Saudi Arabia. Oman Med J. 2018;33(5):409-415. doi: 10.5001/omj.2018.75
- Mousa A, Mandili RL, Aljahdali M, et al. Maternal and fetal outcomes of preeclampsia with and without severe features in King Abdulaziz University Hospital, Jeddah, Saudi Arabia: a retrospective study. Cureus. 2022;14(11). doi: 10.7759/cureus.31013
- Khan B, Yar RA, Khan Khakwani A, Karim S, Ali HA. Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors. Cureus. 2022;14(11). doi: 10.7759/cureus.31143
- Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia—current management and future approach. Curr Pharm Biotechnol. 2018;19(10):786-796. doi: 10.2174/1389201019666180925120109
- Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104. doi: 10.1016/j.preghy.2014.02.001
- Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534-543. doi: 10.1111/j.1600-0897.2010.00831.x
- Laresgoiti-Servitje E, Gómez-López N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16(5):510-524. doi: 10.1093/humupd/dmq007
- Michalczyk M, Celewicz A, Celewicz M, Woźniakowska-Gondek P, Rzepka R. The role of inflammation in the pathogenesis of preeclampsia. Mediators Inflamm. 2020;2020(1):3864941. doi: 10.1155/2020/3864941
- Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J. Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol. 2011;187(7):3671-3682. doi: 10.4049/jimmunol.1100130
- Kara AE, Guney G, Tokmak A, Ozaksit G. The role of inflammatory markers hs-CRP, sialic acid, and IL-6 in the pathogenesis of preeclampsia and intrauterine growth restriction. Eur Cytokine Netw. 2019;30(1):29-33. doi: 10.1684/ecn.2019.0423
- Tjoa M, Van Vugt J, Go A, Blankenstein M, Oudejans C, Van Wijk I. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003;59(1):29-37. doi: 10.1016/S0165-0378(02)00085-2
- Dangat K, Wadhwani N, Randhir K, et al. Longitudinal profile of high-sensitivity C-reactive protein in women with pre-eclampsia. Am J Reprod Immunol. 2023;90(2). doi: 10.1111/aji.13741
- Kusuma AANJ, Darmayasa IM, Widiyanti ES, Maharta IGBA. High C-reactive protein serum levels as a risk factor for preeclampsia. Eur J Med Health Sci. 2024;6(4):9-14. doi: 10.24018/ejmed.2024.6.4.2140
- Ryu A, Cho NJ, Kim YS, Lee EY. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine (Baltimore). 2019;98(18):e15462. doi: 10.1097/MD.0000000000015462
- Kuwabara M, Fukuuchi T, Aoki Y, et al. Exploring the multifaceted nexus of uric acid and health: a review of recent studies on diverse diseases. Biomolecules. 2023;13(10):1519. doi: 10.3390/biom13101519
- Kassahun W, Kidanewold A, Koira G, Biresaw G, Shiferaw M. Hematological predictors of preeclampsia among pregnant women attending ante-natal clinic at Arba Minch General Hospital, South Ethiopia: a comparative cross-sectional study. Pract Lab Med. 2024;39:e00362. doi: 10.1016/j.plabm.2024.e00362
- Bozdag H, Bor E, Akdeniz E. The predictive value of total leukocyte count and leukocyte differential for severe preeclampsia. Perinat J. 2018;26(1):25-31. doi: 10.2399/prn.18.0261007
- Araújo DC, de Macedo AA, Veloso AA, et al. Complete blood count as a biomarker for preeclampsia with severe features diagnosis: a machine learning approach. BMC Pregnancy Childbirth. 2024;24(1):628. doi: 10.1186/s12884-024-06821-4
- Shariff M, Al-Qahtani F, Al-Qahtani M. Comparative study of hematological parameters in the third trimester of hypertensive and normotensive pregnant women. Saudi J Pathol Microbiol. 2020;5(9):408-413. doi: 10.36348/sjpm.2020.v05i09.004
- Puttaiah A, Kirthan JA, Sadanandan DM, Somannavar MS. Inflammatory markers and their association with preeclampsia among pregnant women: a systematic review and meta-analysis. Clin Biochem. 2024;129:110778. doi: 10.1016/j.clinbiochem.2024.110778
- Guan X, Fu Y, Liu Y, et al. The role of inflammatory biomarkers in the development and progression of pre-eclampsia: a systematic review and meta-analysis. Front Immunol. 2023;14:1156039. doi: 10.3389/fimmu.2023.1156039
- American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260. doi: 10.1097/AOG.0000000000003891
- Hamadeh R, Mohsen A, Kobeissy F, Karouni A, Akoum H. C-reactive protein for prediction or early detection of pre-eclampsia: a systematic review. Gynecol Obstet Invest. 2021;86(1-2):13-26. doi: 10.1159/000515530
- Shakarami A, Ghafarzadeh M, Yari F, Fathi L. Association between maternal serum uric acid and preeclampsia. Arch Physiol Biochem. 2022;128(6):1434-1437. doi: 10.1080/13813455.2020.1773863
- Bellos I, Pergialiotis V, Loutradis D, Daskalakis G. The prognostic role of serum uric acid levels in preeclampsia: a meta-analysis. J Clin Hypertens (Greenwich). 2020;22(5):826-834. doi: 10.1111/jch.13865
- Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol. 2009;26(10):729-732. doi: 10.1055/s-0029-1223285
- Ceyhan T, Beyan C, Başer I, Kaptan K, Güngör S, Ifran A. The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume. Ann Hematol. 2006;85(5):320-322. doi: 10.1007/s00277-006-0091-7
